We previously demonstrated that the human lymphoblastoid B cell line (LCL)
TOFE, derived from normal human bone marrow, is permissive to HCV infection
. In this report we developed an in vitro HCV adsorption-inhibition assay b
ased on TOFE cells, to reveal the presence of neutralizing antibodies in se
ra from acutely infected patients.